Citadel Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$766K Buy
26,784
+5,200
+24% +$165K ﹤0.01% 8856
2026
Q1
$679K Buy
+21,584
New +$680K ﹤0.01% 8553
2025
Q4
Sell
-194,131
Closed -$4.9M 13872
2025
Q3
$4.9M Buy
+194,131
New +$4.73M ﹤0.01% 4398
2025
Q2
Sell
-210,694
Closed -$4.89M 14709
2025
Q1
$4.82M Buy
210,694
+203,423
+2,798% +$4.91M ﹤0.01% 3939
2024
Q4
$184K Sell
7,271
-6,976
-49% -$177K ﹤0.01% 10580
2024
Q3
$355K Sell
14,247
-135,213
-90% -$4M ﹤0.01% 8961
2024
Q2
$4.43M Buy
149,460
+30,169
+25% +$837K ﹤0.01% 3943
2024
Q1
$3.6M Sell
119,291
-11,046
-8% -$306K ﹤0.01% 4493
2023
Q4
$3.73M Buy
+130,337
New +$3.83M ﹤0.01% 4261
2023
Q3
Sell
-3,120
Closed -$119K 14992
2023
Q2
$122K Sell
3,120
-6,108
-66% -$239K ﹤0.01% 10633
2023
Q1
$337K Sell
9,228
-184,671
-95% -$5.83M ﹤0.01% 9145
2022
Q4
$5.97M Buy
+193,899
New +$6.02M ﹤0.01% 3573

Other funds holding RTO

Citadel Advisors's RTO Position: Q2 2026 in Review

Citadel Advisors increased its Rentokil (RTO) stake by 24% in Q2 2026, buying an estimated $165K and bringing the position to 26,784 shares worth $766K. The position accounts for ﹤0.01% of the portfolio, ranked #8856.

Citadel Advisors first reported a position in RTO in Q4 2022 and has held it in 12 quarters since. The position peaked at $5.97M in Q4 2022. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Citadel Advisors held 26,784 shares of Rentokil worth $766K as of Q2 2026.
  • Citadel Advisors bought 5,200 Rentokil shares in Q2 2026, an estimated $165K.
  • Rentokil made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8856 holding.
  • Citadel Advisors first reported a position in Rentokil in Q4 2022 and has held it in 12 quarters since.
  • Citadel Advisors's Rentokil position peaked at $5.97M in Q4 2022.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.